請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99242完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李財坤 | zh_TW |
| dc.contributor.advisor | Tsai-Kun Li | en |
| dc.contributor.author | 林家名 | zh_TW |
| dc.contributor.author | Chia-Ming Lin | en |
| dc.date.accessioned | 2025-08-21T16:57:13Z | - |
| dc.date.available | 2025-08-22 | - |
| dc.date.copyright | 2025-08-21 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-08-06 | - |
| dc.identifier.citation | 一、 英文參考文獻
1. Angelo, L. B. (2020). Shared decision-making for vaccines. Journal of the American Pharmacists Association. 2. Austvoll-Dahlgren, A., & Helseth, S. (2010). What informs parents’ decision-making about childhood vaccinations? Journal of Advanced Nursing, 66(11), 2421-2430. 3. Brunson, E. K. (2013). The impact of social networks on parents’ vaccination decisions. Pediatrics, 131(5), e1397–e1404. 4. Berry, S. D., Baier, R. R., Syme, M., Gouskova, N., Bishnoi, C., Patel, U., Leitson, M., Gharpure, R., Stone, N. D., Link-Gelles, R., & Gifford, D. R. (2022). Strategies associated with COVID-19 vaccine coverage among nursing home staff. Journal of the American Geriatrics Society, 70(1), 19–28. 5. Barbieri, C., & Couto, M. (2015). Decision-making on childhood vaccination by highly educated parents. Revista de Saúde Pública, 49. 6. Basu, A., & Dutta, M. J. (2008). The relationship between health information seeking and community participation: the roles of health information orientation and efficacy. Health Communication, 23(1), 70-79. 7. Baumgaertner, B. O., Carlisle, J. E., & Justwan, F. (2018). The influence of political ideology and trust on willingness to vaccinate. PLoS ONE, 13(1). 8. Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., & Böhm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One, 13(12), e0208601. 9. Bonten, M. J. M., et al. (2015). Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. New England Journal of Medicine, 372(12), 1114-1125. 10. Brewer, N. T., Chapman, G. B., Gibbons, F. X., Gerrard, M., McCaul, K. D., & Weinstein, N. D. (2007). Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Health Psychology, 26(2), 136-145. 11. Bridges, C., Hurley, L. P., Williams, W., Ramakrishnan, A., Dean, A. K., & Groom, A. (2015). Meeting the challenges of immunizing adults. American Journal of Preventive Medicine, 49(6 Suppl 4), S455-S464. 12. Bruel, S., Leclercq, T., Ginzarly, M., Botelho-Nevers, E., Frappé, P., & Gagneux-Brunon, A. (2020). Patient decision aid in vaccination: A systematic review of the literature. Expert Review of Vaccines, 19, 305-311. 13. Bussink-Voorend, D., Hautvast, J. L. A., Vandeberg, L., et al. (2022). A systematic literature review to clarify the concept of vaccine hesitancy. Nature Human Behaviour, 6, 1634-1648. 14. Burt, R. S. (2004). Structural holes and good ideas. American Journal of Sociology, 110(2), 349–399. 15. Cannon, K., et al. (2021). A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults ≥ 65 years with prior pneumococcal vaccination. Vaccine, 39(51), 7494-7502. 16. CDC. (1988). Adult Immunization: Knowledge, Attitudes, and Practices — DeKalb and Fulton Counties, Georgia, 1988. 17. CDC. (2019). More Effort Is Needed To Ensure Patients Understand Doctors’ Instructions. 18. CDC. (2024). Strengthen Vaccination Communications. IQIP: Immunization Quality Improvement for Providers. 19. Centers for Disease Control and Prevention. (2023). Pneumonia Vaccine Recommendations for Older Adults. 20. Centers for Disease Control and Prevention. (2022). Impact of Pneumococcal Vaccination on Hospitalization Rates. 21. Champion, V. L. (1984). Instrument development for health belief model constructs. Advances in Nursing Science, 6(3), 73-85. 22. Champion, V. L., & Skinner, C. S. (2008). The health belief model. In Health Behavior and Health Education (4th ed., pp. 45-65). Jossey-Bass. 23. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Lawrence Erlbaum. 24. Connolly, T., & Reb, J. (2012). Toward interactive, internet-based decision aid for vaccination decisions: Better information alone is not enough. Vaccine, 30(25), 3813-3818. 25. Connolly, T. (2014). Towards Interactive, Internet-Based Decision Aid for Vaccination Decisions: Better Information Alone Is Not Enough. 26. Chou C-H, Lee Y-S, Lin C-W, et al. Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan. J Formos Med Assoc. 2024;123:322-330. 27. Centers for Disease Control and Prevention (CDC). Coverage with influenza, RSV and COVID-19 vaccines among U.S. nursing-home residents—Early 2024-25 season. MMWR. 2024;73:1203-1209. 28. Centers for Medicare & Medicaid Services. Medicare vaccine coverage and payment. 2021. 29. Creswell, J. W., & Creswell, J. D. (2017). Research design: Qualitative, quantitative, and mixed methods approaches. Sage publications. 30. Christakis, N. A., & Fowler, J. H. (2007). The spread of obesity in a large social network over 32 years. The New England journal of medicine, 357(4), 370–379. 31. Degnan, A., Berry, K., Sweet, D., Abel, K., Crossley, N., & Edge, D. (2018). Social networks and symptomatic and functional outcomes in schizophrenia: a systematic review and meta-analysis. Social psychiatry and psychiatric epidemiology, 53, 873-888. 32. Daley, M. F., Narwaney, K. J., Shoup, J. A., Wagner, N. M., & Glanz, J. M. (2018). Addressing parents’ vaccine concerns: A randomized trial of a social media intervention. American Journal of Preventive Medicine, 55(1), 44-54. 33. de Gomensoro, E., Del Giudice, G., & Doherty, T. M. (2018). Challenges in adult vaccination. Annals of Medicine, 50(3), 181-192. 34. Dubé, E., Gagnon, D., & MacDonald, N. E. (2013). Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine, 33(34), 4191-4203. 35. Dubenske, L. L., Gustafson, D. H., Shaw, B. R., & Cleary, J. F. (2008). Web-based cancer communication and decision-making systems. Medical Decision Making, 28(4), 555-565. 36. Dunn, A. G., Surian, D., Leask, J., Dey, A., Mandl, K. D., & Coiera, E. (2017). Mapping information exposure on social media and HPV vaccine coverage in the U.S. Vaccine, 35, 3033-3040. 37. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older U.S. Adults: A Test-Negative Design. (2018). Clinical Infectious Diseases, 67(10), 1498-1506. 38. Field, A. (2018). Discovering Statistics Using IBM SPSS Statistics (5th ed.). Sage. 39. Field, R., & Caplan, A. (2012). Evidence-based decision making for vaccines: The need for an ethical foundation. Vaccine, 30(6), 1009-1013. 40. Glanz, K., Rimer, B. K., & Viswanath, K. (2008). Health Behavior and Health Education (4th ed.). Jossey-Bass. 41. Global Burden of Disease Study 2016. (2018). Estimates of lower respiratory infections, 1990–2016. The Lancet Infectious Diseases. 42. Global Burden of Disease Study 2021. (2023). Non-COVID-19 lower respiratory infections, 1990–2021. The Lancet. 43. Gong, F., Gong, Z., Li, Z., Min, H., Zhang, J., Li, X., Fu, T., Fu, X., He, J., Wang, Z., Wang, Y., & Wu, Y. (2022). Impact of Media Use on Chinese Public Behavior towards Vaccination with the COVID-19 Vaccine: A Latent Profile Analysis. Vaccines, 10(10), 1737. 44. Guo, Y., Lu, Z., Kuang, H., & Wang, C. (2020). Information avoidance on social network sites. International Journal of Information Management, 52, 102067. 45. Henrich, N., & Holmes, B. (2011). What the public was saying about the H1N1 vaccine: perceptions and issues discussed in on-line comments during the 2009 H1N1 pandemic. PloS one, 6(4), e18479. 46. Hair, J. F., Hult, G. T. M., Ringle, C. M., & Sarstedt, M. (2019). A Primer on Partial Least Squares Structural Equation Modelling (2nd ed.). Sage. 47. Hair, J. F., Black, W. C., Babin, B. J., & Anderson, R. E. (2019). Multivariate Data Analysis (8th ed.). Cengage Learning. 48. Hair, J. F., Hult, G. T. M., Ringle, C. M., & Sarstedt, M. (2021). A Primer on Partial Least Squares Structural Equation Modelling (3rd ed.). Sage. 49. Hashmi, F. S., Soroya, S. H., & Mahmood, K. (2024). Assessing the impact of health information orientation and health information literacy on patients’ engagement with health information. Journal of Information Science, 0(0). 50. Hsiao, A., et al. (2025). Effectiveness of PCV13 against invasive pneumococcal disease in older adults. Vaccine, 44, 126543. 51. Hurley, L. P., Bridges, C., Harpaz, R., et al. (2014). U.S. physicians’ perspective on adult vaccine delivery. Annals of Internal Medicine, 160, 161-170. 52. Hiroshima University. Community vaccination program reduces pneumonia deaths among elderly in Japan, Sera Town. 2025. 53. Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education Quarterly, 11(1), 1-47. 54. Jones, C. J., Smith, H., & Llewellyn, C. (2014). Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review. Health psychology review, 8(3), 253–269. 55. Kang, G. J., Ewing-Nelson, S. R., Mackey, L., Schlitt, J., Marathe, A., Abbas, K. M., … & Fowler, E. F. (2017). Semantic network analysis of vaccine sentiment in online social media. Vaccine, 35(29), 3621–3638. 56. Kawczak, S., Mooney, M., Mitchner, N., Senatore, V., & Stoller, J. K. (2020). The impact of a quality improvement continuing medical education intervention on physicians' vaccination practice: a controlled study. Human vaccines & immunotherapeutics, 16(11), 2809–2815. 57. Kirbiš A. The Impact of Socioeconomic Status, Perceived Threat and Healthism on Vaccine Hesitancy. Sustainability. 2023; 15(7):6107. 58. Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M., & Paterson, P. (2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine, 32(19), 2150–2159. 59. Limbu, Y. B., Gautam, R. K., & Pham, L. (2022). The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines, 10(6), 973. 60. Lu, P. J., Hung, M. C., Srivastav, A., et al. (2021). Adult vaccination coverage—United States, 2018. MMWR Surveillance Summaries, 70(3), 1-26. 61. Ly, S., Runacres, F., & Poon, P. (2021). Journey mapping as a novel approach to healthcare: A qualitative mixed methods study in palliative care. BMC Health Services Research, 21, 915. 62. Martin, L. R., & Petrie, K. J. (2017). The Vaccination Attitudes Examination (VAX) scale. Annals of Behavioral Medicine, 51(5), 652-660. 63. Matanock, A. M., Lee, G. M., Gierke, R., et al. (2019). Updated PCV13/PPSV23 recommendations for adults ≥ 65. MMWR, 68, 1069-1075. 64. Mays, N., & Pope, C. (2006). Assessing quality in qualitative research. BMJ, 323(7319), 107-111. 65. Ministry of Health, Labour and Welfare, Japan. (2022). Elderly Influenza Vaccination in Japan: A Public Health Perspective. 66. Moore, J. F. (1993). Predators and prey: A new ecology of competition. Harvard Business Review, 71(3), 75-86. 67. Muscat, D. M., et al. (2021). Health literacy and shared decision-making. Journal of General Internal Medicine, 36(2), 521-524. 68. Myers, L. B., & Goodwin, R. (2011). Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health, 11, 15. 69. Martín-Caro Álvarez, D., García-Iglesias, J., Rojas-Chicote, C., Ruiz-Tornero, A. M., Mozo-Martín, M. R., Barrios-Escudero, V., Rodríguez-Barrientos, R., & Working group of the Residential Care Unit of the Community of Madrid (Addenda) (2025). Pneumococcal vaccination coverage: Residential Care Unit of the Community of Madrid. Cobertura de vacunación frente al neumococo: Unidad de Atención a Residencias de la Comunidad de Madrid. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 38(4), 033.2025. 70. Ministry of Health Singapore. National Adult Immunisation Schedule. 2024. 71. Ministry of Health, Labour and Welfare (Japan). 高齢者肺炎球菌ワクチンの接種状況. 2023. 72. Marsden, P. V. (2002). Egocentric and sociocentric measures of network centrality. Social Networks, 24(4), 407–422. 73. NACI (National Advisory Committee on Immunization). Update on the use of pneumococcal vaccines in adults ≥65 years. 2023. 74. Nivel. Vaccine coverage of the Dutch national pneumococcal vaccination programme—Adults 2022. 2023. 75. NHS England South West. Adult vaccination programmes toolkit 2023/24. 2023. 76. Norman, C. D., & Skinner, H. A. (2006). eHealth literacy: Essential skills for consumer health. Journal of Medical Internet Research, 8(2), e9. 77. Nutbeam, D. (2000). Health literacy as a public health goal. Health Promotion International, 15(3), 259-267. 78. Patel, J., Noureldin, M., Fakhouri, D., Farraye, F. A., Kovar-Gough, I., Warren, B., Waljee, A. K., & Piper, M. S. (2023). Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Digestive diseases and sciences, 68(7), 2921–2935. 79. Pallant, J. (2020). SPSS Survival Manual (7th ed.). McGraw-Hill Education. 80. Pleasant, A. (2011). Health literacy: An opportunity to improve global health. New Directions for Adult and Continuing Education, 2011(130), 43-53. 81. Quinn, S. C., Parmer, J., Freimuth, V. S., Hilyard, K. M., Musa, D., & Kim, K. H. (2013). Exploring communication, trust in government, and vaccination intention later in the 2009 H1N1 pandemic: results of a national survey. Biosecurity and bioterrorism : biodefense strategy, practice, and science, 11(2), 96–106. 82. Ramirez, J. A., et al. (2017). Adults hospitalized with pneumonia in the U.S.: Incidence and mortality. Clinical Infectious Diseases, 65(11), 1806-1812. 83. Rogers, E. M., Singhal, A., & Quinlan, M. M. (2014). Diffusion of innovations. In An Integrated Approach to Communication Theory and Research (pp. 432-448). Routledge. 84. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2(4), 328-335. 85. Sings, H. L., De Wals, P., Gessner, B. D., Isturiz, R., Laferriere, C., McLaughlin, J. M., Pelton, S., Schmitt, H. J., Suaya, J. A., & Jodar, L. (2019). Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(12), 2135–2143. 86. Schmid, P., Rauber, D., Betsch, C., Lidolt, G., & Denker, M.-L. (2017). Barriers to influenza vaccination intention and behaviour. PLoS ONE, 12(1), e0170550. 87. Sørensen, K., et al. (2012). Health literacy and public health: A systematic review. BMC Public Health, 12, 80. 88. Stevenson C G, McArthur M A, Naus M, et al. Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities. CMAJ. 2001;164:1413-1419. 89. Thaler, R. H., & Sunstein, C. R. (2008). Nudge: Improving Decisions About Health, Wealth, and Happiness. Yale University Press. 90. Thompson, R. D., & Williams, H. K. (2023). Pneumococcal vaccine effectiveness in LTC settings. Vaccine, 41(8), 1445-1452. 91. Taiwan Centers for Disease Control. Get a flu shot for health and happiness: government-funded vaccination campaign expands. 2023. 92. Vaccines4Life. Influencing adult pneumonia vaccination policy—Germany country report. 2021. 93. Vila-Córcoles A, Ochoa-Gondar O, de Diego-Cabanes C, et al. Pneumococcal vaccination coverages among older adults in Catalonia, Spain, 2017. Euro Surveill. 2019;24:1800083. 94. Whitehead, H. S., French, C. E., Caldwell, D. M., et al. (2023). Communication interventions to counter vaccine misinformation. Vaccine, 41, 1018-1034. 95. Wilson, S., & Wiysonge, C. (2020). Social media and vaccine hesitancy. BMJ Global Health, 5. 96. World Health Organization. (2017). Safety of Vaccines: WHO Vaccine Safety Basics. 97. World Health Organization. (2021). Vaccination Policies for Elderly Populations Worldwide. 98. World Health Organization. Herd immunity, lockdowns and COVID-19. 2021. 99. Wheelock, A., Miraldo, M., Parand, A., Vincent, C., & Sevdalis, N. (2014). Journey to vaccination: a protocol for a multinational qualitative study. BMJ open, 4(1), e004279. 100. Kim, Y., Taniguchi, H., Okuyama, K., Kamimoto, J., & Kawakami, K. (2025). Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey. Human vaccines & immunotherapeutics, 21(1), 2461814. 101. Valente, T. W. (2010). Social Networks and Health: Models, Methods, and Applications. Oxford University Press. 102. Zens K D, Kienzle F, von Wyl V, et al. Adult pneumococcal vaccination coverage in Switzerland: a nationwide study. Front Public Health. 2022;10:987654. 103. Zhang, W., Yang, X., Tao, K., Zhu, Y., & Zhang, M. (2022). Media framing and cognition of COVID-19 vaccine effectiveness. American Journal of Health Behavior, 46(4), 423-441. 二、 中文參考資料 1. 台灣資料:中華民國政府公告與衛生署監測資料 2. GeneOnline 編輯部(2023年8月22日)。RSV疫苗戰漸趨白熱化,上市核准新進展一次看。GeneOnline。 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99242 | - |
| dc.description.abstract | 近年來,新興傳染病的威脅與高齡化社會的快速發展,使得疫苗接種意願(vaccine uptake intention)成為公共衛生政策關注的重點。然而,現有文獻大多聚焦於中壯年族群或一般老年人,對於「超高齡長者」(≥85 歲),特別是居住於高齡住宅社區的族群,其疫苗接種行為的研究相對有限。此類高齡者常同時面臨多重生理退化、慢性疾病、社交孤立與行動限制,導致其疫苗接種決策過程更為複雜,不僅仰賴個人風險認知或健康知識,更高度依賴醫療服務的可近性、社會支持與外部提示(cues to action)。
本研究以肺炎鏈球菌疫苗(PCV)為例,結合健康信念模式(Health Belief Model, HBM)、健康素養模型(Health Literacy Model, HLM)與多重行動線索(cue to action)構面,採用混合方法設計(Mixed Methods Design),深入剖析高齡者疫苗接種的多變項決策歷程。量化部分透過結構式問卷調查高齡住宅社區居民之疫苗知覺與行為傾向,並透過PLS-SEM統計模式進行驗證,找出不同因素的路徑關係找出關鍵因素,質性部分則進行深度訪談,包含社區醫護人員與住民與關鍵衛生單位與藥廠單位,探討其接種歷程中所遭遇之挑戰、影響與考量因素。 研究結果顯示,高齡者的疫苗接種意願受多重心理與社會因素交互影響。健康信念模型中之三項關鍵構面:「知覺效益」(Perceived Benefits)、「知覺障礙」(Perceived Barriers)與「自我效能」(Self-Efficacy),對於疫苗接種意願具顯著且直接的影響。在設計疫苗推廣策略時,須同時針對「利益最大化」與「障礙最小化」進行溝通設計,提升接受度。此外,「政策提示」(policy)為影響疫苗接種意願最具統計顯著性的行動線索,突顯政府制度設計與資源導入在行為轉化過程中之核心地位。特別是在高齡族群中,制度保障與可近性(accessibility)被視為行動決策的主要依據(如:免費接種、公費涵蓋、設站方便性)。在中介影響上,健康素養可透過知覺效益、知覺障礙與自我效能三構面進一步影響接種意圖。此外,社會網絡與媒體傳播的間接效果與實務潛力,因此親友經驗分享、媒體傳播像是LINE群組訊息與地方衛生政策皆為重要的行動線索來源,進一步引導接種行為。 本研究進一步建構出一套整合性策略模型,指出疫苗接種決策不應單一歸因於個體特質,因此本研究進一步以構建一個滿足五大節點的疫苗生態系(vaccination ecosystem)觀點建構高齡者疫苗推廣的系統性模型已回應疫苗的病患旅程地圖,疫苗接種行為的「系統性養成」:從認知啟動、信念轉化、意願產生到行動實踐,每一階段均可對應不同的策略接觸點(touchpoints),並由多元行動者依其角色進行串聯與補位。具體而言,政府部門、醫療機構、社區組織、媒體平台與疫苗供應商共同構成疫苗推廣的五大節點,各自發揮其「制度建構」、「專業背書」、「社會動員」、「訊息傳播」與「產品支持」的功能。並延伸可以再看到「三重協同效應」策略模型(triple synergy model),指出當政府資源補助與衛生單位的政策推廣(policy)為核心去串聯,媒體訊息傳播(正向的疫苗氣氛營造)、醫療專業支持(知識與健康素養的提升)及社區動員行動(社會網絡實體接觸與情感連線)三者同步啟動時,可以影響三個疫苗意願的三大信念(知覺效益、知覺障礙、自我效能),進而可產生接種意願的乘數效果(multiplicative effect)三層影響力 本文建議未來政策設計應強化社區型健康促進介入、建立信任導向的溝通平台,並提升照護現場的數位管理與決策支援系統。藉由整合性理解與介入,有望提升高齡者疫苗覆蓋率,進而強化台灣面對高齡社會的公共衛生韌性。 | zh_TW |
| dc.description.abstract | In recent years, the dual challenges of emerging infectious diseases and rapid population aging have elevated vaccination uptake intention as a critical issue in public health. However, most existing research focuses on middle-aged or general elderly populations, with limited attention to the “super-elderly” (≥85 years) populations, particularly those residing in elderly housing communities. These individuals often face complex decision-making processes influenced not only by personal risk perception and knowledge but also by limited mobility, social isolation, multimorbidity, and reliance on healthcare accessibility, social support, and external cues to action.
This study uses the pneumococcal conjugate vaccine (PCV) as a case to explore the multivariate decision-making process behind vaccination among the elderly. It integrates the Health Belief Model (HBM), Health Literacy Model (HLM), and multiple cues to action through a mixed methods design. Quantitative data were collected via structured questionnaires among residents in wellness villages and analyzed using Partial Least Squares Structural Equation Modeling (PLS-SEM) to identify direct and indirect determinants. Qualitative interviews were conducted with community healthcare providers, residents, government health officers, and pharmaceutical stakeholders to further explore influencing factors and contextual challenges. Findings reveal that seniors’ vaccination intentions are shaped by intertwined psychological and social factors. Three key HBM constructs—perceived benefits, perceived barriers, and self-efficacy—show significant direct impacts on vaccination intention. Policy-driven cues were identified as the most statistically significant, highlighting the pivotal role of institutional design, accessibility (e.g., free vaccination, site convenience), and public resource allocation. Health literacy demonstrated an indirect influence through HBM constructs. Additionally, cues such as media dissemination (e.g., LINE groups), peer influence, and local health policy formed important triggers for behavioral activation. This study proposes an integrative strategy model emphasizing the vaccination ecosystem, structured around five critical stakeholders—government, healthcare providers, community organizations, media, and vaccine suppliers—each contributing to system-level support through institutional governance, professional endorsement, community mobilization, media framing, and product delivery. The model also introduces a triple synergy framework, suggesting that synchronized engagement across policy reinforcement, media influence, and professional-community collaboration can amplify perceived benefits, reduce barriers, and enhance self-efficacy—resulting in a multiplicative effect on vaccination intention. The study concludes by advocating for trust-based communication platforms, community-driven health promotion, and digital support systems in elderly care, aiming to increase vaccine coverage among the oldest-old and enhance public health resilience in Taiwan's aging society. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-08-21T16:57:13Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-08-21T16:57:13Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員審定書 i
誌謝 ii 中文摘要 iv 英文摘要 vi 目次 ix 圖次 xii 表次 xiii 第一章 緒論 1 第一節 疫苗背景說明與PESTEL分析宏觀環境影響因素 1 第二節 肺炎鏈球菌感染盛行率與疾病負擔 3 第三節 肺炎鏈球菌感染預防醫學與疫苗有效性 6 第四節 台灣疫苗猶豫現況與施打狀況 7 第五節 研究動機 8 第六節 研究問題與目的 9 第七節 研究流程 10 第八節 預期研究貢獻 14 第二章 文獻討論 15 第一節 疫苗施打意願決策的潛在因素多層面分析與策略探討 15 一、 健康信念與健康素養 15 二、 醫療提供者介入 23 三、 社交網絡影響 24 四、 政府與衛生單位政策影響 24 五、 大眾傳播媒體推廣 25 六、 疫苗施打態度與意願與疫苗決策和行動 27 第二節 提升成人疫苗接種率的策略與挑戰:以終身免疫為視角 28 第三節 預防醫學與疫苗在高齡者社區中的角色與國際做法之比較 30 第五節 疫苗施打病患旅程地圖分析(Patient Journey Mapping) 36 第六節 高齡住宅社區與社會網絡Social Network行為 38 第七節 創新擴散理論在新疫苗推廣模型中的應用 39 第三章 研究方法 42 第一節 研究方法與架構 42 第二節 模型基礎與構面定義 44 第三節 問卷設計、研究變數與問項 45 第四節 研究設計與假設 51 第五節 研究構念與分析方法 53 第六節 資料來源與蒐集 55 第四章 資料分析與研究發現 58 第一節 疫苗施打病患旅程地圖 58 第二節 資料分析方法與流程 61 第三節 有效樣本描述統計 68 第四節 結構方程式分析結果 68 第五節 單因子變異數分析結果 83 第六節 Media 分析:高齡者疫苗與健康資訊的獲取來源 88 第七節 Social network 分析:社會網絡結構對疫苗接種行為的影響 — 結構洞、中心性與葡萄串現象的交織 89 第八節 專家意見質化訪談住民疫苗施打意願的決定因素 93 第九節 創新擴散理論在新疫苗推廣模型中的應用 104 第五章 結論與討論 107 第一節 研究發現與實務意涵 107 第二節 商業生態系與疫苗推廣:病患旅程下的策略整合 113 第三節 未來肺炎鏈球菌接種建議與推廣方向 116 第四節 高齡與多重疾病長者之疫苗接種意願:本研究與國際調查之比較 118 第五節 研究限制與未來研究方向 119 第六節 研究價值 120 參考文獻 122 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 健康信念模式與健康素養 | zh_TW |
| dc.subject | 疫苗接種意願與健康政策 | zh_TW |
| dc.subject | 高齡者長者疫苗決策 | zh_TW |
| dc.subject | 高齡住宅之預防醫學 | zh_TW |
| dc.subject | 疫苗生態系與三重協同效應 | zh_TW |
| dc.subject | 肺炎球菌疫苗 | zh_TW |
| dc.subject | 行動線索之政府政策與社會網絡與媒體傳播及醫療介入 | zh_TW |
| dc.subject | and Medical Intervention | en |
| dc.subject | Vaccine Decision-Making Among Older Adults | en |
| dc.subject | Preventive Medicine in Elderly Housing | en |
| dc.subject | Vaccination Intention and Health Policy | en |
| dc.subject | Health Belief Model and Health Literacy | en |
| dc.subject | Cues to Action: Government Policy | en |
| dc.subject | Social Networks | en |
| dc.subject | Media Communication | en |
| dc.subject | Pneumococcal Vaccine | en |
| dc.subject | Vaccination Ecosystem and Triple Synergy Model | en |
| dc.title | HBM,HLM疫苗的多變項決策分析與健康促進的策略模型於高齡長者:以PCV疫苗為例 | zh_TW |
| dc.title | Vaccination Decision Analysis for Seniors Based on HBM and HLM: Exploring the Impact of Health Beliefs, Health Literacy, and Multiple Cues on Respiratory Disease Vaccine Intentions in Elderly Housing and Community | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.coadvisor | 胡凱焜 | zh_TW |
| dc.contributor.coadvisor | Kae-Kuen Hu | en |
| dc.contributor.oralexamcommittee | 潘令妍;林志明 | zh_TW |
| dc.contributor.oralexamcommittee | Ling-Yen Pan;Chi-Ming Lin | en |
| dc.subject.keyword | 高齡者長者疫苗決策,高齡住宅之預防醫學,疫苗接種意願與健康政策,健康信念模式與健康素養,行動線索之政府政策與社會網絡與媒體傳播及醫療介入,肺炎球菌疫苗,疫苗生態系與三重協同效應, | zh_TW |
| dc.subject.keyword | Vaccine Decision-Making Among Older Adults,Preventive Medicine in Elderly Housing,Vaccination Intention and Health Policy,Health Belief Model and Health Literacy,Cues to Action: Government Policy, Social Networks, Media Communication, and Medical Intervention,Pneumococcal Vaccine,Vaccination Ecosystem and Triple Synergy Model, | en |
| dc.relation.page | 134 | - |
| dc.identifier.doi | 10.6342/NTU202502972 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2025-08-10 | - |
| dc.contributor.author-college | 進修推廣學院 | - |
| dc.contributor.author-dept | 生物科技管理碩士在職學位學程 | - |
| dc.date.embargo-lift | N/A | - |
| 顯示於系所單位: | 生物科技管理碩士在職學位學程 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-2.pdf 未授權公開取用 | 2.79 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
